← Back to Search

Stigma Counseling for HIV Prevention

N/A
Recruiting
Led By Lisa A Eaton, PhD
Research Sponsored by University of Connecticut
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 or older
Men (based on male sex assignment at birth)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will study how stigma and substance use affect pre-exposure prophylaxis (PrEP) use for HIV prevention among black sexual minority men.

Who is the study for?
This trial is for Black men and transwomen over the age of 18, who use substances, have had condomless sex with a man in the past six months, and are HIV negative. Participants must identify as part of the African diaspora and will be tested for recent substance use.
What is being tested?
The study is examining stigma counseling as an intervention to encourage pre-exposure prophylaxis (PrEP) usage among participants. It aims to understand how stigma and substance use affect PrEP adherence for HIV prevention in this demographic.
What are the potential side effects?
While specific side effects are not listed for stigma counseling interventions, participants may experience emotional or psychological discomfort when discussing sensitive topics related to substance use, sexual practices, or experiences of stigma.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I was assigned male at birth.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
PrEP Use
Secondary study objectives
PrEP stigma

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Stigma Counseling for PrEP AccessExperimental Treatment1 Intervention
Behavioral counseling

Find a Location

Who is running the clinical trial?

University of ConnecticutLead Sponsor
189 Previous Clinical Trials
160,348 Total Patients Enrolled
Lisa A Eaton, PhDPrincipal InvestigatorUniversity of Connecticut
1 Previous Clinical Trials
600 Total Patients Enrolled

Media Library

Stigma Counseling for PrEP Access Clinical Trial Eligibility Overview. Trial Name: NCT04832477 — N/A
HIV Research Study Groups: Stigma Counseling for PrEP Access
HIV Clinical Trial 2023: Stigma Counseling for PrEP Access Highlights & Side Effects. Trial Name: NCT04832477 — N/A
Stigma Counseling for PrEP Access 2023 Treatment Timeline for Medical Study. Trial Name: NCT04832477 — N/A
~135 spots leftby Feb 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top